SI1304107T1 - Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze - Google Patents

Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze

Info

Publication number
SI1304107T1
SI1304107T1 SI9830786T SI9830786T SI1304107T1 SI 1304107 T1 SI1304107 T1 SI 1304107T1 SI 9830786 T SI9830786 T SI 9830786T SI 9830786 T SI9830786 T SI 9830786T SI 1304107 T1 SI1304107 T1 SI 1304107T1
Authority
SI
Slovenia
Prior art keywords
oxazolidinines
derivatives
treating psoriasis
psoriasis
treating
Prior art date
Application number
SI9830786T
Other languages
English (en)
Inventor
Donald H. Batts
Roger G. Ulrich
Original Assignee
Pharmacia & Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company Llc filed Critical Pharmacia & Upjohn Company Llc
Publication of SI1304107T1 publication Critical patent/SI1304107T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9830786T 1997-11-18 1998-11-10 Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze SI1304107T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6568997P 1997-11-18 1997-11-18
US7129798P 1998-01-16 1998-01-16
US7524798P 1998-02-19 1998-02-19
EP02028171A EP1304107B1 (en) 1997-11-18 1998-11-10 Use of oxazolidinines derivatives for treating psoriasis

Publications (1)

Publication Number Publication Date
SI1304107T1 true SI1304107T1 (sl) 2005-10-31

Family

ID=34743570

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830786T SI1304107T1 (sl) 1997-11-18 1998-11-10 Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze

Country Status (7)

Country Link
EP (1) EP1304107B1 (sl)
AT (1) ATE299021T1 (sl)
DE (1) DE69830811T2 (sl)
DK (1) DK1304107T3 (sl)
ES (1) ES2243650T3 (sl)
PT (1) PT1304107E (sl)
SI (1) SI1304107T1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11608320B2 (en) 2020-02-02 2023-03-21 Kuwait University Oxazolidinone hydroxamic acid derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0610265B1 (en) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CN1046276C (zh) * 1993-11-22 1999-11-10 法玛西雅厄普约翰美国公司 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途

Also Published As

Publication number Publication date
DE69830811D1 (de) 2005-08-11
ATE299021T1 (de) 2005-07-15
DE69830811T2 (de) 2006-04-27
DK1304107T3 (da) 2005-08-22
EP1304107B1 (en) 2005-07-06
EP1304107A2 (en) 2003-04-23
EP1304107A3 (en) 2003-11-19
PT1304107E (pt) 2005-09-30
ES2243650T3 (es) 2005-12-01

Similar Documents

Publication Publication Date Title
TW249226B (sl)
HU912359D0 (en) The use of flupirtine active agents for treating muscle-tension
EP0102534A3 (en) Hair-growing agent
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
NO944339L (no) Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser
NO944340D0 (no) Melatoninderivater for anvendelse ved behandling av desynkroniseringstilstander
SI1304107T1 (sl) Uporaba oksazolidinonskih derivatov za zdravljenje psoriaze
SI1032386T1 (sl) Uporaba oksazolidinonskih derivatov za zdravljenje artritisa
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
SI0836853T1 (sl) Uporaba bradikininskih antagonistov za pripravo zdravil za zdravljenje in preprečevanje Alzheimerjeve bolezni
DE59813136D1 (de) Verwendung von Thiaminen zur Herstellung eines Arzneimittels zur Prophylaxe und zur Therapie der diabetischen Retinopathie und der diabetischen Nephropathie